Ho‐Min Chen
Papers
1
Total Citations
16
H-Index
1
About
Ho-Min Chen is a leading urological oncologist whose research has significantly advanced the understanding of prostate cancer surgery outcomes. Her key research areas encompass surgical oncology, comparative effectiveness research, and cancer epidemiology. Chen’s major contribution lies in rigorously evaluating real-world outcomes of different radical prostatectomy techniques—open, laparoscopic, and robotic—using large-scale national databases. Her landmark 2020 study, drawing from the National Cancer Database, demonstrated no significant differences in positive surgical margin rates or biochemical failure–free survival among the three surgical approaches, challenging assumptions about robotic surgery’s superiority. This work, with 16 citations, provides critical evidence for surgical decision-making and healthcare policy. Chen’s research is notable for its methodological rigor, employing nationwide cohort data to produce generalizable findings that directly impact clinical practice. By clarifying that surgical approach does not independently predict oncologic outcomes, she has helped shift focus toward surgeon experience and patient-specific factors. Her contributions continue to inform urologists and patients navigating treatment choices, establishing her as a trusted voice in evidence-based surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1